Reviva Pharmaceuticals Holdings (RVPH) Earnings Date & Reports

A.I. Advisor

published Earnings

RVPH is expected to report earnings to fall 10.77% to -23 cents per share on November 11

Reviva Pharmaceuticals Holdings RVPH Stock Earnings Reports

Q3'24

Est.

$-0.23

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.13

Q4'23

Missed

by $0.03

Q3'23

Missed

by $0.08

The last earnings report on August 15 showed earnings per share of -25 cents, beating the estimate of -30 cents. With 271.22K shares outstanding, the current market capitalization sits at 42.03M.

View a ticker or compare two or three

Compare

RVPH

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RVPH
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a blank check company, which focuses on the merger, capital stock exchange, asset acquisition, stock purchase, reorganization, recapitalization, and exchangeable share transaction.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

19925 Stevens Creek Boulevard

Phone

+1 408 501-8881

Employees

Web

https://www.revivapharma.com